{"id":"W4313462518","doi":"10.1038/s41388-022-02566-6","title":"Novel inhibition of AKR1C3 and androgen receptor axis by PTUPB synergizes enzalutamide treatment in advanced prostate cancer","year":2023,"lang":"en","type":"article","venue":"Oncogene","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia","funders":"Comprehensive Cancer Center, University of California, Davis; National Institute of Environmental Health Sciences; U.S. Department of Health and Human Services; National Institutes of Health; National Cancer Institute; University of California, Davis; U.S. Department of Defense","keywords":"Enzalutamide; Prostate cancer; Androgen receptor; Cancer research; Biology; Cancer; Androgen; Androgen deprivation therapy; Internal medicine; Endocrinology; Medicine; Hormone","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001858513,0.0004533728,0.0005913495,0.0003243146,0.0002463169,0.0004741001,0.0004338463,0.0002923991,0.003382922],"category_scores_gemma":[0.00009595535,0.0001784994,0.0004888615,0.0003394663,0.0002632283,0.0002556396,0.0002433068,0.001261579,0.0006419433],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004703765,"about_ca_system_score_gemma":0.0006674019,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001011655,"about_ca_topic_score_gemma":0.004306994,"domain_scores_codex":[0.9998775,0.00001967899,0.00001006165,0.00001651657,0.00002671326,0.00004966414],"domain_scores_gemma":[0.9999694,0.000003167913,0.000006349172,0.000004806117,0.000003494335,0.00001288567],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.008282703,0.002145357,0.002107909,0.0006685556,0.0003284414,0.0004722786,0.00006030465,0.001877223,0.8762169,0.001288394,0.004433117,0.1021188],"study_design_scores_gemma":[0.003957966,0.01647814,0.03599909,0.00009804986,0.0009879597,0.002942283,0.0002316509,0.006598429,0.8681512,0.0008240158,0.06365041,0.00008081198],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9741864,0.0123912,0.002366272,0.0007591961,0.0003052579,0.000169298,0.001154749,0.0006945526,0.00797307],"genre_scores_gemma":[0.9913307,0.003826816,0.001204091,0.0001496134,0.00003168102,0.00008743424,0.001019702,0.00002770424,0.002322204],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003382922,"threshold_uncertainty_score":0.01131701,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02506186331074932,"score_gpt":0.3264781597186497,"score_spread":0.3014162964079004,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}